A. Onat

G. Can, A. Onat, N. Coban, 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases.

G. Can, A. Onat, 2014, Current pharmaceutical design.

Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A‐I determine marked cardiometabolic risk

G. Can, A. Onat, V. Sansoy, 2013, European journal of clinical investigation.

The APOE -219G/T and +113G/C polymorphisms affect insulin resistance among Turks.

T. Lehtimäki, N. Mononen, M. Kähönen, 2011, Metabolism: clinical and experimental.

Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk

G. Can, A. Onat, S. Altay, 2015, Journal of Investigative Medicine.

Glycated hemoglobin measurement and prediction of cardiovascular disease.

J. Gallacher, J. Danesh, D. Lawlor, 2014, JAMA.

Normal thyroid-stimulating hormone levels, autoimmune activation, and coronary heart disease risk

G. Can, A. Onat, S. Altay, 2015, Endocrine.

Advances in understanding gender difference in cardiometabolic disease risk

A. Onat, Y. Karadeniz, A. Kaya, 2016, Expert review of cardiovascular therapy.

Gender specific association of ABCA1 gene R219K variant in coronary disease risk through interactions with serum triglyceride elevation in Turkish adults.

G. Can, A. Onat, N. Coban, 2013, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

Cross-sectional study of complement C3 as a coronary risk factor among men and women.

G. Can, A. Onat, H. Uyarel, 2005, Clinical science.

Cross-sectional study of complement C 3 as a coronary risk factor among men and women

G. Can, A. Onat, H. Uyarel, 2005 .

Serum apolipoprotein C‐III in high‐density lipoprotein: a key diabetogenic risk factor in Turks

G. Can, A. Onat, E. Ayhan, 2009, Diabetic medicine : a journal of the British Diabetic Association.

Metabolic syndrome: nature, therapeutic solutions and options

A. Onat, 2011, Expert opinion on pharmacotherapy.

Obesity in Turkish adults: Prevalence, validity as coronary risk factor, and interrelation with other risk factors

A. Onat, M. Şenocak, 1995 .

Repositioning of the global epicentre of non-optimal cholesterol

Gretchen A. Stevens, Tran Quoc Bao, S. R. Rao, 2020, Nature.

Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension.

G. Can, A. Onat, N. Erginel-Unaltuna, 2015, Archives of medical research.

Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.

G. Can, A. Onat, H. Uyarel, 2007, Atherosclerosis.

Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance

G. Can, A. Onat, H. Uyarel, 2007, Sleep and Breathing.

Systolic, diastolic, and pulse pressures as coronary risk factors in a population with low cholesterol levels: A prospective 10‐year evaluation

A. Onat, V. Sansoy, B. Erer, 2003, Clinical cardiology.

Pediatric Metabolic Syndrome: From Prevention to Treatment

R. Kelishadi, S. Gidding, A. Onat, 2012, Cholesterol.

Distinction of hypertriglyceridemic waist phenotype from simple abdominal obesity: interaction with sex hormone-binding globulin levels to confer high coronary risk

G. Can, A. Onat, B. Şimşek, 2017, Postgraduate medicine.

Prospective evidence for physical activity protecting Turkish adults from metabolic disorders

A. Onat, G. Çan, Z. Kaya, 2007 .

Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction

A. Onat, L. Tokgözoğlu, N. Koylan, 2003, Clinical cardiology.

Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity

A. Onat, H. Çakır, Y. Karadeniz, 2014, Expert review of cardiovascular therapy.

Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.

G. Can, A. Onat, H. Uyarel, 2007, Metabolism: clinical and experimental.

Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range

J. Tuomilehto, A. Onat, S. Söderberg, 2010, Diabetes Care.

Metabolic Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based Study

A. Onat, H. Uyarel, S. Albayrak, 2006 .

Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey

G. Can, A. Onat, S. Karakoyun, 2016, Anatolian journal of cardiology.

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

Gretchen A. Stevens, T. F. Rinke de Wit, R. Malekzadeh, 2020, The Lancet.

Evidence for a complex risk profile in obese postmenopausal Turkish women with hypertriglyceridaemia and elevated apolipoprotein B.

G. Can, A. Onat, A. Sniderman, 2004, Clinical science.

Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks

T. Lehtimäki, G. Can, A. Onat, 2016, Molecular Biology Reports.

Pediatric Metabolic Syndrome: From Prevention to Treatment Pediatric Metabolic Syndrome: From Prevention to Treatment

R. Kelishadi, H. Asayesh, M. Qorbani, 2012 .

Diminishing benefits of urban living for children and adolescents’ growth and development

Mohammad Reza Mohammadi, Md. Mahmudur Rahman, Gretchen A. Stevens, 2023, Nature.

Negative results in screening for possible new sequence variations on ATP-binding cassette transporter A1 gene in Turkish adults with metabolic syndrome.

A. Onat, N. Coban, F. Geyik, 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Familial sinus node disease and degenerative myopia—a new hereditary syndrome?

A. Onat, 1986, Human Genetics.

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.

G. Can, A. Onat, Z. Kaya, 2010, Metabolism: clinical and experimental.

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk.

A. Onat, G. Hergenç, 2011, Metabolism: clinical and experimental.

Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.

Altan Onat, A. Onat, V. Sansoy, 2005, Metabolism: clinical and experimental.

Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults.

N. Mononen, A. Onat, M. Hurme, 2009, Atherosclerosis.

Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.

G. Can, A. Onat, M. Uğur, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Algorithm for predicting CHD death risk in Turkish adults: conventional factors contribute only moderately in women

G. Can, A. Onat, M. Keskin, 2017, Anatolian journal of cardiology.

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

Gretchen A. Stevens, Tran Quoc Bao, R. Malekzadeh, 2020, eLife.

Non-Contact Respiratory Rate Estimation in Real-Time With Modified Joint Unscented Kalman Filter

Tansu Filik, Altan Onat, Can Uysal, 2020, IEEE Access.

A Novel and Computationally Efficient Joint Unscented Kalman Filtering Scheme for Parameter Estimation of a Class of Nonlinear Systems

Altan Onat, A. Onat, 2019, IEEE Access.

Apparent Sex-Specific Divergence of Acylation Stimulating Protein Levels With Respect to Metabolic Parameters of Pathogenetic and Clinical Relevance

K. Cianflone, G. Can, A. Onat, 2012 .

BLOOD PRESSURE LEVELS IN TURKISH ADULTS: INITIAL TREND TO IMPROVED BLOOD PRESSURE CONTROL

A. Onat, H. Uyarel, V. Sansoy, 2002 .

Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) –482C>T polymorphism on triglyceride concentration in Turkish adults

G. Can, A. Onat, V. Sansoy, 2012, Clinical chemistry and laboratory medicine.

Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis

J. Gallacher, J. Danesh, A. Peters, 2017, American journal of epidemiology.

Low Serum Uric Acid Predicts Risk of a Composite Disease Endpoint

G. Can, A. Onat, S. Altay, 2021, Medicina.

Shared underlying dynamics between heart failure and cancer: autoimmune activation?

A. Onat, S. Altay, A. Kaya, 2016, European journal of heart failure.

Effectiveness of a standard secondary coronary prevention program: not obligate

A. Onat, 2016, Anatolian journal of cardiology.

Comment on Ye et al. The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal? Diabetes 2014;63:332–342

A. Onat, S. Altay, H. Yüksel, 2014, Diabetes.

Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders

G. Can, A. Onat, S. Altay, 2013, Scandinavian journal of clinical and laboratory investigation.

Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease

G. Can, A. Onat, S. Altay, 2013, Clinical Rheumatology.

Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.

A. Onat, 2004, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

Renal “hyperfiltrators” are at elevated risk of death and chronic diseases

G. Can, A. Onat, S. Altay, 2014, BMC Nephrology.

Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation

G. Can, A. Onat, S. Albayrak, 2007, International Journal of Obesity.

C-reactive protein and coronary heart disease in western Turkey.

A. Onat, O. Uysal, I. Keles, 2001, The American journal of cardiology.

Cigarette smoking and beneficial effect on cardiometabolic risk: A reply

A. Onat, 2010 .

We-P11:114 Discordance between insulin resistance and metabolic syndrome

G. Can, A. Onat, I. Sari, 2006 .

Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy.

A. Onat, H. Direskeneli, 2012, Current pharmaceutical design.

Serum γ‐Glutamyltransferase: Independent Predictor of Risk of Diabetes, Hypertension, Metabolic Syndrome, and Coronary Disease

G. Can, A. Onat, E. Ayhan, 2012, Obesity.

Particle swarm optimization based parametrization of adhesion and creep force models for simulation and modelling of railway vehicle systems with traction

Petr Voltr, Altan Onat, A. Onat, 2020, Simul. Model. Pract. Theory.

Velocity measurement-based friction estimation for railway vehicles running on adhesion limit: swarm intelligence-based multiple models approach

Petr Voltr, Altan Onat, A. Onat, 2020, J. Intell. Transp. Syst..

A new friction condition identification approach for wheel–rail interface

Petr Voltr, Michael Lata, Altan Onat, 2017 .

Gender-modulated risk of coronary heart disease, diabetes and coronary mortality among Turks for three major risk factors, and residual adiposity risk

G. Can, A. Onat, Y. Karadeniz, 2016, BMC Endocrine Disorders.

Low acylation stimulating protein levels are associated with cardiometabolic disorders–secondary to autoimmune activation?

G. Can, A. Onat, S. Altay, 2016, Anatolian journal of cardiology.

[Turkish Adult Risk Factor Study survey 2012: overall and coronary mortality and trends in the prevalence of metabolic syndrome].

G. Can, A. Onat, M. Aydın, 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.

G. Can, A. Onat, N. Erginel-Unaltuna, 2010, Nutrition.

Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism.

G. Can, A. Onat, N. Erginel-Unaltuna, 2015, Clinica chimica acta; international journal of clinical chemistry.

Association of serum albumin levels with traditional risk factors and insulin resistance among Turkish adults

G. Can, A. Onat, H. Uyarel, 2007 .

Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease.

A. Onat, V. Sansoy, O. Uysal, 1999, International journal of cardiology.

Depressive Symptoms in a General Population: Associations with Obesity, Inflammation, and Blood Pressure

G. Can, A. Onat, E. Ayhan, 2011, Cardiology research and practice.

The Risk Factor Survey of 2003 in Western Turkey Indicates Trend to Declining Coronary Mortality and Urban Overall Mortality

A. Onat, H. Uyarel, V. Sansoy, 2003 .

High Absolute Coronary Disease Risk among Turks: Involvement of Risk Factors Additional to Conventional Ones

G. Can, A. Onat, M. Uğur, 2010, Cardiology.

Autoimmune activation, a fundamental mechanism of coronary artery disease risk, missed by inadequate analysis.

A. Onat, H. Yuksel, 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women

G. Can, A. Onat, B. Şimşek, 2016, Archives of medical science : AMS.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

Gretchen A. Stevens, M. M. Rahman, W. Rathmann, 2016, Lancet.

A linear Kalman filtering scheme for estimation of secondary vertical suspension of railway vehicles

Michael Lata, Onur Kılınç, Altan Onat, 2016 .

Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331â€ˆ288 participants

Gretchen A. Stevens, W. Rathmann, O. Franco, 2015 .

Investigations Plasma Lipoproteins and Apolipoproteins in Turkish Adults: Overall Levels, Associations with Other Risk Parameters and HDL's Role as a Marker of Coronary Risk in Women

A. Onat, V. Sansoy, I. Keles, 1999 .

Prevalence of All-cause and Coronary Mortality in Turkish Adults as Assessed by 8-year Follow-up Data of the Turkish Adult Risk Factor Study

A. Onat, V. Sansoy, I. Keles, 1999 .

Little contribution of conventional factors in an algorithm to predicting death risk in Turkish adults.

G. Can, A. Onat, D. Ural, 2017, International journal of cardiology.

Observations contributing to certain aspects of the mechanism of spontaneous reciprocating tachycardia.

A. Onat, 1972, British heart journal.

[Regional distribution of all-cause mortality and coronary disease incidence in Turkey: findings of Turkish Adult Risk Factor survey 2010].

G. Can, A. Onat, E. Ayhan, 2011, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Insulin Resistance Syndrome: Main Villain of Current and Rising Coronary Risk Among Turks.

A. Onat, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Tenth categories of total and HDL cholesterol fail to independently predict death risk in middle-aged Turkish adults.

G. Can, A. Onat, M. Keskin, 2017, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers Halkmzda serum asimetrik dimetilarginin düzeyleri: Kadnda metabolik sendromla iliki ve sigara içicilerde düük düzeylere eilim

A. Onat, A. Karabulut, G. Hergenç, 2008 .

Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks

T. Lehtimäki, G. Can, A. Onat, 2016, Molecular Biology Reports.

Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.

G. Can, A. Onat, Z. Kaya, 2010, Metabolism: Clinical and Experimental.

Sex- and Obesity-specific Association of Aromatase (CYP19A1) Gene Variant with Apolipoprotein B and Hypertension.

G. Can, A. Onat, N. Erginel-Unaltuna, 2015, Archives of medical research.

C-reactive protein, fibrinogen, and cardiovascular disease prediction.

J. Gallacher, J. Danesh, D. Lawlor, 2012, The New England journal of medicine.

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.

J. Gallacher, J. Danesh, E. Rimm, 2012, International journal of epidemiology.

Visceral adipose tissue and body fat mass: predictive values for and role of gender in cardiometabolic risk among Turks.

G. Can, A. Onat, M. Uğur, 2010, Nutrition.

Turkey’s recent collaborative and genuine contributors to medicine

A. Onat, 2015, Anatolian journal of cardiology.

Prospective Assessment of Influences of Alcohol Consumption on Risk Parameters, Metabolic Syndrome and Coronary Risk in Turkish Adults

A. Onat, H. Uyarel, V. Sansoy, 2003 .

[Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition].

G. Can, A. Onat, G. Hergenç, 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk.

A. Onat, G. Hergenç, 2011, Metabolism: clinical and experimental.

Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.

A. Onat, B. Şimşek, Tuğba Akbaş, 2016, Journal of the American College of Cardiology.

Systematic Reviews andMeta- and Pooled Analyses Useof RepeatedBloodPressure andCholesterolMeasurements to Improve Cardiovascular DiseaseRiskPrediction: An Individual-Participant-DataMeta-Analysis

J. Danesh, R. Kronmal, V. Salomaa, 2017 .

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

M. Jarvelin, K. Stronks, R. Martorell, 2023, Nature Medicine.

Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults.

G. Can, A. Onat, N. Erginel-Unaltuna, 2014, Clinica chimica acta; international journal of clinical chemistry.

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

A. M. Alshangiti, Tran Quoc Bao, James P. Wirth, 2024, The Lancet.

Combined Hypercholesterolemia and Hypertension Among Turkish Adults: Prevalence and Prediction of Cardiovascular Disease Risk

G. Can, A. Onat, V. Sansoy, 2004 .

Assessment of the Cohort of the Turkish Risk Factor Study with Framingham Risk Function: an Additional Indicator of the High Absolute Coronary Risk Among Turks

A. Onat, O. Uysal, G. Hergenç, 2001 .

An algorithm to predict risk of Type 2 diabetes in Turkish adults: Contribution of C-reactive protein

G. Can, A. Onat, E. Ayhan, 2010, Journal of endocrinological investigation.

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Daniel F. Freitag, T. Assimes, D. Chasman, 2012, The Lancet.

Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.

G. Can, A. Onat, E. Ayhan, 2009, Metabolism: clinical and experimental.